The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients

被引：0
|
作者：
Ruiz, C [1 ]
Barros, A [1 ]
Motta, E [1 ]
Pinotti, J [1 ]
机构：
[1] CTR REFERENCIA SAUDE MULHER,SAO PAULO,BRAZIL
来源：
BREAST | 1997年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：P949 / P949
页数：1
相关论文
共 50 条
  • [31] Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapy
    Bonneterre, J.
    Revillion, F.
    Desauw, C.
    Blot, E.
    Kramar, A.
    Fournier, C.
    Hornez, L.
    Peyrat, J. P.
    [J]. ONCOLOGY REPORTS, 2013, 29 (01) : 355 - 361
  • [32] Pathologic complete response is an independent prognostic factor for locoregional recurrence in locally advanced breast cancer patients after neoadjuvant chemotherapy.
    Chou, Hsu-Huan
    Chen, Shin-Che
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 65 - 66
  • [33] Prognostic role of breast pathologic complete response after neoadjuvant chemotherapy in node-positive breast cancer patients
    Woo, J.
    Ryu, J. M.
    Lee, S. K.
    Yu, J.
    Lee, J. E.
    Kim, S. W.
    Nam, S. J.
    Chae, B. J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S23 - S23
  • [34] Neoadjuvant chemotherapy in patients with breast cancer
    Jakesz, R
    Taucher, S
    Gnant, M
    Gebhard, B
    Kandioler, D
    Rudas, M
    Djavanmard, M
    Steger, G
    [J]. ZENTRALBLATT FUR CHIRURGIE, 1998, 123 : 147 - 150
  • [35] Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
    Li, Xinyan
    Wang, Mozhi
    Wang, Mengshen
    Yu, Xueting
    Guo, Jingyi
    Sun, Tie
    Yao, Litong
    Zhang, Qiang
    Xu, Yingying
    [J]. JOURNAL OF BREAST CANCER, 2019, 22 (04) : 497 - 521
  • [36] Prognostic Factors in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Wada, N.
    Yoneyama, K.
    Yamauchi, C.
    Fujii, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S140 - S140
  • [37] Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Ozdemir, Ozlem
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Yilmaz, Cengiz
    Durusoy, Raika
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (02) : 167 - 171
  • [38] Prognostic factors in patients with operable breast cancer who received neoadjuvant chemotherapy
    Horiguchi, J.
    Takata, D.
    Nagaoka, R.
    Fujii, T.
    Sato, A.
    Tokiniwa, H.
    Higuchi, T.
    Uchida, S.
    Tsuboi, M.
    Yajima, R.
    Kikuchi, M.
    Ino, Y.
    Oyama, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S94 - S94
  • [39] Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
    Yaewon Yang
    Seock-Ah Im
    Bhumsuk Keam
    Kyung‑Hun Lee
    Tae‑Yong Kim
    Koung Jin Suh
    Han Suk Ryu
    Hyeong-Gon Moon
    Sae‑Won Han
    Do‑Youn Oh
    Wonshik Han
    Tae‑You Kim
    In Ae Park
    Dong-Young Noh
    [J]. BMC Cancer, 16
  • [40] Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
    Yang, Yaewon
    Im, Seock-Ah
    Keam, Bhumsuk
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Suh, Koung Jin
    Ryu, Han Suk
    Moon, Hyeong-Gon
    Han, Sae-Won
    Oh, Do-Youn
    Han, Wonshik
    Kim, Tae-You
    Park, In Ae
    Noh, Dong-Young
    [J]. BMC CANCER, 2016, 16
12345